(IMCD) IMCD - Overview
Stock: Specialty Chemicals, Ingredients, Additives, Polymers, Lubricants
Dividends
| Dividend Yield | 1.84% |
| Yield on Cost 5y | 2.22% |
| Yield CAGR 5y | 20.49% |
| Payout Consistency | 94.8% |
| Payout Ratio | 46.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.1% |
| Relative Tail Risk | -8.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.82 |
| Alpha | -53.32 |
| Character TTM | |
|---|---|
| Beta | 0.225 |
| Beta Downside | 0.228 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.12% |
| CAGR/Max DD | -0.30 |
Description: IMCD IMCD January 10, 2026
IMCD N.V. is a Dutch-based specialty-chemical distributor that sells a broad portfolio-including adhesives, flame retardants, pigments, surfactants, UV filters, and fuel additives-to customers across Europe, the Middle East, Africa, the Americas, and Asia-Pacific. The firm acts as an intermediary between manufacturers and end-users, providing formulation expertise and logistics support for a wide range of industries such as automotive, construction, consumer goods, and energy.
Based on the latest FY-2023 figures disclosed in the company’s annual report, IMCD generated roughly €5.5 billion in revenue with an adjusted EBITDA margin of about 13 %, reflecting modest profitability in a sector that is sensitive to raw-material price swings and regulatory changes (e.g., REACH and EU Green Deal mandates). Growth has been anchored by rising demand for sustainable polymers and high-performance additives in electric-vehicle battery enclosures and lightweight construction, while the firm’s exposure to volatile oil-derived feedstocks remains a key risk driver. The company’s operating cash-flow conversion has consistently exceeded 80 %, supporting a dividend yield near 2 % and a modest share-repurchase program.
For a deeper quantitative view, you may want to explore IMCD’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 408.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.26 > 1.0 |
| NWC/Revenue: 11.03% < 20% (prev 16.42%; Δ -5.38% < -1%) |
| CFO/TA 0.08 > 3% & CFO 386.5m > Net Income 408.0m |
| Net Debt (1.54b) to EBITDA (876.2m): 1.76 < 3 |
| Current Ratio: 1.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.2m) vs 12m ago 3.76% < -2% |
| Gross Margin: 21.04% > 18% (prev 0.12%; Δ 2093 % > 0.5%) |
| Asset Turnover: 164.5% > 50% (prev 106.9%; Δ 57.58% > 0%) |
| Interest Coverage Ratio: 9.68 > 6 (EBITDA TTM 876.2m / Interest Expense TTM 69.2m) |
Altman Z'' 3.05
| A: 0.17 (Total Current Assets 1.86b - Total Current Liabilities 1.07b) / Total Assets 4.63b |
| B: 0.20 (Retained Earnings 915.6m / Total Assets 4.63b) |
| C: 0.15 (EBIT TTM 669.4m / Avg Total Assets 4.39b) |
| D: 0.24 (Book Value of Equity 637.9m / Total Liabilities 2.65b) |
| Altman-Z'' Score: 3.05 = A |
Beneish M -3.16
| DSRI: 0.77 (Receivables 916.4m/734.3m, Revenue 7.22b/4.44b) |
| GMI: 0.55 (GM 21.04% / 11.65%) |
| AQI: 1.02 (AQ_t 0.57 / AQ_t-1 0.56) |
| SGI: 1.63 (Revenue 7.22b / 4.44b) |
| TATA: 0.00 (NI 408.0m - CFO 386.5m) / TA 4.63b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of IMCD shares?
Over the past week, the price has changed by +2.93%, over one month by +0.30%, over three months by -9.65% and over the past year by -45.64%.
Is IMCD a buy, sell or hold?
What are the forecasts/targets for the IMCD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 113.4 | 42.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 71.9 | -9.4% |
IMCD Fundamental Data Overview February 03, 2026
P/E Trailing = 16.9934
P/E Forward = 12.3001
P/S = 0.9482
P/B = 2.3488
Revenue TTM = 7.22b EUR
EBIT TTM = 669.4m EUR
EBITDA TTM = 876.2m EUR
Long Term Debt = 1.32b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 356.0m EUR (from shortTermDebt, last quarter)
Debt = 1.73b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.54b EUR (from netDebt column, last quarter)
Enterprise Value = 6.13b EUR (4.59b + Debt 1.73b - CCE 190.4m)
Interest Coverage Ratio = 9.68 (Ebit TTM 669.4m / Interest Expense TTM 69.2m)
EV/FCF = 16.68x (Enterprise Value 6.13b / FCF TTM 367.6m)
FCF Yield = 6.00% (FCF TTM 367.6m / Enterprise Value 6.13b)
FCF Margin = 5.09% (FCF TTM 367.6m / Revenue TTM 7.22b)
Net Margin = 5.65% (Net Income TTM 408.0m / Revenue TTM 7.22b)
Gross Margin = 21.04% ((Revenue TTM 7.22b - Cost of Revenue TTM 5.70b) / Revenue TTM)
Gross Margin QoQ = 26.02% (prev 10.99%)
Tobins Q-Ratio = 1.33 (Enterprise Value 6.13b / Total Assets 4.63b)
Interest Expense / Debt = 1.85% (Interest Expense 32.1m / Debt 1.73b)
Taxrate = 25.55% (44.5m / 174.2m)
NOPAT = 498.4m (EBIT 669.4m * (1 - 25.55%))
Current Ratio = 1.75 (Total Current Assets 1.86b / Total Current Liabilities 1.07b)
Debt / Equity = 0.88 (Debt 1.73b / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = 1.76 (Net Debt 1.54b / EBITDA 876.2m)
Debt / FCF = 4.20 (Net Debt 1.54b / FCF TTM 367.6m)
Total Stockholder Equity = 1.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.29% (Net Income 408.0m / Total Assets 4.63b)
RoE = 21.29% (Net Income TTM 408.0m / Total Stockholder Equity 1.92b)
RoCE = 20.71% (EBIT 669.4m / Capital Employed (Equity 1.92b + L.T.Debt 1.32b))
RoIC = 19.87% (NOPAT 498.4m / Invested Capital 2.51b)
WACC = 5.27% (E(4.59b)/V(6.32b) * Re(6.74%) + D(1.73b)/V(6.32b) * Rd(1.85%) * (1-Tc(0.26)))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.86%
[DCF Debug] Terminal Value 86.05% ; FCFF base≈373.5m ; Y1≈363.0m ; Y5≈363.1m
Fair Price DCF = 157.9 (EV 10.87b - Net Debt 1.54b = Equity 9.32b / Shares 59.0m; r=5.90% [WACC]; 5y FCF grow -3.92% → 2.90% )
EPS Correlation: 38.79 | EPS CAGR: 96.11% | SUE: 0.11 | # QB: 0
Revenue Correlation: 81.62 | Revenue CAGR: 21.87% | SUE: 1.89 | # QB: 1
EPS next Year (2026-12-31): EPS=5.80 | Chg30d=-0.359 | Revisions Net=-5 | Growth EPS=+4.6% | Growth Revenue=+4.1%